MALERBA, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 2.406
NA - Nord America 2.204
AS - Asia 1.286
SA - Sud America 167
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 6.103
Nazione #
US - Stati Uniti d'America 2.161
IT - Italia 1.003
RU - Federazione Russa 411
SG - Singapore 409
CN - Cina 293
NL - Olanda 188
SE - Svezia 183
IE - Irlanda 162
VN - Vietnam 134
KR - Corea 126
BR - Brasile 124
DE - Germania 118
TR - Turchia 89
HK - Hong Kong 69
GB - Regno Unito 67
UA - Ucraina 63
AT - Austria 52
FI - Finlandia 44
FR - Francia 40
IN - India 30
JP - Giappone 25
CA - Canada 20
BE - Belgio 17
IQ - Iraq 17
MX - Messico 17
PL - Polonia 16
BD - Bangladesh 15
ID - Indonesia 14
ZA - Sudafrica 14
AR - Argentina 13
ES - Italia 13
IL - Israele 11
CH - Svizzera 10
PK - Pakistan 10
EC - Ecuador 9
CO - Colombia 8
SA - Arabia Saudita 8
PH - Filippine 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
LT - Lituania 5
UZ - Uzbekistan 5
DZ - Algeria 4
EU - Europa 4
BO - Bolivia 3
CZ - Repubblica Ceca 3
KZ - Kazakistan 3
OM - Oman 3
AU - Australia 2
BG - Bulgaria 2
CL - Cile 2
CR - Costa Rica 2
ET - Etiopia 2
JO - Giordania 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
PY - Paraguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
NC - Nuova Caledonia 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 6.103
Città #
Pisa 849
Ashburn 324
Singapore 251
Chandler 218
Dallas 194
Amsterdam 185
Dublin 162
San Jose 144
Jacksonville 128
Seoul 126
Boardman 106
Moscow 104
New York 88
Ann Arbor 87
Los Angeles 71
Izmir 62
The Dalles 57
Hong Kong 56
Vienna 52
Hefei 49
Wilmington 45
Ho Chi Minh City 42
Munich 42
Beijing 32
Boston 32
Hanoi 32
Millbury 25
Council Bluffs 24
Mestre 24
Tokyo 23
Istanbul 22
Kent 22
Bremen 20
Lauterbourg 20
San Mateo 18
Frankfurt am Main 17
Woodbridge 17
Brussels 16
North Bergen 16
Buffalo 15
Falls Church 15
Santa Clara 15
Chicago 14
Rome 14
Turku 14
Warsaw 14
Helsinki 13
Lawrence 13
Jakarta 12
Ogden 12
Johannesburg 11
London 11
Padova 11
Seattle 11
Washington 11
Chennai 10
Houston 10
Montreal 10
Orem 10
São Paulo 10
Bern 9
Guangzhou 9
Holon 9
Milan 9
Stockholm 9
Bientina 8
Denver 8
Haiphong 8
Princeton 8
San Luis Obispo 8
Scuola 8
Columbus 7
Mexico City 7
Atlanta 6
Baghdad 6
Barnet 6
Shanghai 6
Dearborn 5
Düsseldorf 5
Ferrara 5
Jeddah 5
Las Vegas 5
Toronto 5
Wuhan 5
Curitiba 4
Genoa 4
Hải Dương 4
Jiaxing 4
Lompoc 4
Manchester 4
Nanjing 4
Nuremberg 4
Quito 4
Salt Lake City 4
Tashkent 4
Auburn Hills 3
Belo Horizonte 3
Berlin 3
Biên Hòa 3
Bến Tre 3
Totale 4.283
Nome #
A quantitative bioassay to determine the inhibitory potency of NGF-TrkA antagonists 1.119
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 370
A new mechanism for Alzheimer neurodegeneration: functional antagonism between proNGF, mature NGF and their receptors 326
Congenital pain insensitivity mutation in nerve growth factor gene uncouples nociception from central features of pain in heterozygous humans and mice 288
Conformational Rigidity within Plasticity Promotes Differential Target Recognition of Nerve Growth Factor 266
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 266
Nerve growth factor derivative NGF61/100 promotes outgrowth of primary sensory neurons with reduced signs of nociceptive sensitization 258
Over-expression of furin-resistant pro-NGF determines neurodegeneration in transgenic mice 243
ProNGF/NGF inbalance triggers neurodegeneration in transgenic mice. 242
Targeting the cation-chloride co-transporter NKCC1 to re-establish GABAergic inhibition and an appropriate excitatory/inhibitory balance in selective neuronal circuits: a novel approach for the treatment of Alzheimer's disease 241
Intranasal administration of a painless human NGF reduces memory deficit and amyloid oligomers accumulation in APPxPS1 mice 241
Identification of proNGF versus NGF expression fingerprinting in PC12 cells 240
proNGF/NGF mixtures induce gene expression changes in PC12 cells that neither singly produces 240
ProNGFNGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 237
ProNGF Is a Cell-Type-Specific Mitogen for Adult Hippocampal and for Induced Neural Stem Cells 231
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 229
Intranasal administration of an optimized human Nerve Growth Factor reduces memory deficits and amyloid oligomers accumulation in APPxPS1 mice 218
NGF and proNGF Reciprocal Interference in Immunoassays: Open Questions, Criticalities, and Ways Forward 213
Involvement of NGF in early stages of chick embryo development 204
The role of Nerve Growth Factor in development and in ALzheimer's disease 202
Nerve growth factor neutralization promotes oligodendrogenesis by increasing miR-219a-5p levels 164
Cerebrospinal fluid level of proNGF as potential diagnostic biomarker in patients with frontotemporal dementia 143
Totale 6.181
Categoria #
all - tutte 34.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.426


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202190 0 0 0 0 0 0 0 0 0 52 11 27
2021/2022204 12 1 3 12 22 12 7 14 20 13 12 76
2022/2023848 40 66 55 85 48 99 1 186 229 7 16 16
2023/2024313 32 6 25 5 22 91 15 4 24 15 4 70
2024/20251.781 202 10 31 433 128 35 385 22 198 78 113 146
2025/20262.304 190 207 249 291 224 134 385 129 357 138 0 0
Totale 6.181